non-pharmacological and non-hormonal treatments for menopause
A single source asserts that emerging evidence supports the efficacy of non-pharmacological and non-hormonal treatments for menopause when hormone therapy is contraindicated or avoided.
Hypothesized mechanism
Mechanism not yet characterized in the substrate.
This is the model’s proposed mechanism from the sources on file, not a demonstrated causal pathway. How well the published record supports it is reflected in the rigor and plausibility dimensions of the score, and traced to the verbatim sources at the foot of the page.
How the score was reached, for this pair
The composite score is the sum of five dimensions, each scored 0 to 2 by the model from the evidence on file. Below is the sub-score this specific pair received on each, with what that dimension measures. It scored 2 of 10 overall, a exploratory reading, from a direct rated exploratory in strength.
The model’s overall reasoning for this pair is the summary at the top of the page, and the mechanism it proposed is in the section above.
Scored for women. Evidence generated in women (female population). (band F1, ×1.00).
Corroboration
Only a single source ('Managing menopause after cancer.') is cited, and it merely asserts 'emerging evidence' without describing study design or independent replication. A single, vaguely-worded source scores at the bottom of the range.
Rigor
The claim only states that 'emerging evidence supports the efficacy' with no described study design, sample, or methodology. There is no indication of an RCT, meta-analysis, or even an observational study, so it defaults to the lowest tier.
Specificity
Menopause is named directly, but the intervention is a broad umbrella ('non-pharmacological and non-hormonal treatments') rather than a specific named therapy. The lack of a concretely identified intervention limits specificity.
Plausibility
No mechanism of action is described in the claim; it only asserts efficacy in the context of contraindicated hormone therapy. Without any mechanistic statement, plausibility cannot be credited.
Consistency
Only one source and one claim are provided, so directional agreement across studies cannot be assessed. Per the single-study rule, this is scored neutrally at 1.
Layers not covered for this pair
Not covered for this pair. This layer holds documented sex-specific pharmacokinetics for a limited set of drugs, and this compound is not among them yet. A blank here means the drug is not covered by the layer, not that no sex difference exists.
More on the sex-specific pharmacokinetics layer and its sources →Not covered for this pair. The cycle-phase layer is seeded for the strongest-evidence cases so far (PMDD), and this pair is not among them yet. A blank here means the pair is not covered by the layer, not that the effect was found to be phase-independent.
More on the cycle-phase layer and its sources →Source evidence · what the pipeline ingested
These are the sources the pipeline ingested to detect and score this signal, the published literature the model actually read, each tagged by study type. Where the model combined findings the claim is marked as a synthesis (S), and where the literature disagrees the contradiction is shown (!).
Every source below belongs to this signal’s evidence arm, Direct research. Whel reads each drug-condition pair through four such arms, each held to its own inclusion bar; a signal is surfaced through one of them.
- 1emerging evidence supports the efficacy of non-pharmacological and non-hormonal treatments PubMed · PMID 38458217 ↗
These are the verbatim sources the pipeline surfaced and read; they may not be the full published record for a pair, and the score reflects the strength and agreement of the evidence rather than its volume. The strength of these source types is what the rigor dimension of the score reads off. MATRIX, sex-specific pharmacokinetics, and cycle phase are separate layers the pipeline does not ingest, external cross-references reported beside the score, and they link to their own sources in their sections above.
The primary sources and pipelines this evidence is drawn from →